Elucidating the specific pharmacological mechanism of action (MOA) of naturally happening compounds is often tough. Whilst Tarselli et al. (sixty) designed the main de novo artificial pathway to conolidine and showcased that this Normally happening compound successfully suppresses responses to both chemically induced and inflammation-derived discom